Description：

Evacetrapib (LY2484595) is a potent and selective inhibitor of CETP with IC50 of 5.5 nM, elevates HDL cholesterol without increases in aldosterone or blood pressure. Phase 3.

Chemical Information：

Molecular Weight (MW)		638.65
Formula		C31H36F6N6O2
CAS No.		1186486-62-3
Solubility (25°C) *	DMSO	12.8 mg/mL (20.04 mM)
	Water	Insoluble
	Alcohol	12.8 mg/mL (20.04 mM)

Biological Activity：

Targets IC50

Tyrosinase 50 nM

Preparing Stock Solutions

Concentration Volume (DMSO) Mass	1 mg	5 mg	10 mg
1 mM	1.5658 mL	7.8290 mL	15.6580 mL
5 mM	0.3132 mL	1.5658 mL	3.1316 mL
10 mM	0.1566 mL	0.7829 mL	1.5658 mL
50 mM	0.0313 mL	0.1566 mL	0.3132 mL

Bought notes(bought amounts latest0)

No one bought this product

Total 0 records, divided into1 pages. First Prev Next Last